Revive Therapeutics And The Psychedelic Revolution A massive psychedelics boom is already here.
In fact, with the potential to treat a wide range of mental and health issues for millions, it’s opening a wide range of opportunity for companies, like Revive Therapeutics (CSE: RVV) (OTC: RVVTF), which recently announced a $2.75 million acquisition of Psilocin Pharma Corp., a specialty psychedelic sciences company focused on the development of Psilocybin-based therapeutics for various medical needs.
Better still, Revive Therapeutics is investigating novel oral dosage forms of psilocybin, such as oral dissolvable thin films or tablets, based on the company’s wholly-owned patent-pending psilocybin formulations.
The best part – Revive Therapeutics’ psychedelics story has only just begun.
https://thedeepdive.ca/revive-therapeutics-and-the-psychedelic-revolution/